PENTYLENE GLYCOL
What is PENTYLENE GLYCOL (CAS 5343-92-0) in cosmetics and what are its global regulatory limits?
PENTYLENE GLYCOL (CAS No. 5343-92-0) is a verified cosmetic ingredient primarily functioning as Skin Conditioning, Solvent in topical formulations. Regulated under KR MFDS (Unregulated) and EU 1223/2009 CosIng (Unregulated) statutory frameworks, it is typically formulated at 3–8% within an optimal stability window of pH 4–8.
7-Track Official Regulatory Label Names Matrix
Primary Statutory Gazette Only · Zero Machine Translation| Jurisdiction Track | Official Statutory Label Name | One-Click Copy |
|---|---|---|
| 1. Korea (MFDS Standard Name) | PENTYLENE GLYCOL (KR MFDS Registered) | |
| 2. Korea Former Nomenclature History | — | — |
| 3. European Union (EU CosIng Glossary) | PENTYLENE GLYCOL | |
| 4. United States (US PCPC / MoCRA INCI) | PENTYLENE GLYCOL | |
| 5. US FDA OTC Monograph Active Name | — (Cosmetic Inactive / Non-OTC) | — |
| 6. China (NMPA IECIC Standard Name) | 1,2-戊二醇 | |
| 7. Japan (JCIA Standard / MHLW Quasi-Drug) | ペンチレングリコール · [QD: 1,2-ペンタンジオール] |
Layer 1 — Statutory Regulatory Limits Across 6 Regions
| Region | Status | Max Limit | Conditions & Statutory Source |
|---|---|---|---|
| Korea (MFDS) | Unregulated | GMP | Listed in official cosmetic inventory |
| Europe (EU) | Unregulated | GMP | Listed in official cosmetic inventory |
| United States (FDA) | Unregulated | GMP | Listed in official cosmetic inventory |
| China (NMPA) | Listed / Allowed | GMP | IECIC Entry #5 |
| Japan (MHLW) | Unregulated | GMP | Listed in official cosmetic inventory |
| ASEAN (ACD) | Unregulated | GMP | Listed in official cosmetic inventory |
Layer 2 — Toxicological & Historical Safe Use Concentrations (CIR / SCCS / CN IECIC / IFRA)
“EU SCCS Safe Opinion Limit” is the toxicological safe threshold (MoS≥100), whereas “US CIR Reported Max Use” and “CN IECIC Historical Max Use” represent historical maximum concentrations in commercial products.
| Assessment Basis | Application Scope | Concentration Range | Verdict & Dossier Reference |
|---|---|---|---|
| US CIR Reported Max Use | rinse_off | 0.001~5% | Safe (MoS≥100)116_tent_capryl.pdf () |
| US CIR Reported Max Use | eye | 0.005~4% | Safe (MoS≥100)116_tent_capryl.pdf () |
| US CIR Reported Max Use | leave_on | 0.005~5% | Safe (MoS≥100)116_tent_capryl.pdf () |
| US CIR Reported Max Use | hair | 0.001~0.001% | Safe (MoS≥100)116_tent_capryl.pdf () |
| US CIR Reported Max Use | powder | 2~2% | Safe (MoS≥100)116_tent_capryl.pdf () |
| US CIR Reported Max Use | total | 0.001~5% | Safe (MoS≥100)117_draft_cg.pdf () |
| US CIR Reported Max Use | spray | 1~1% | Safe (MoS≥100)119_final_12glc.pdf () |
| US CIR Reported Max Use | dermal | 0.001~5% | Safe (MoS≥100)119_final_12glc.pdf () |
| US CIR Reported Max Use | deodorant | 0.2~0.2% | Safe (MoS≥100)119_final_12glc.pdf () |
| US CIR Reported Max Use | nail | 4~5% | Safe (MoS≥100)119_final_12glc.pdf () |
| US CIR Reported Max Use | mucous | 0.001~5% | Safe (MoS≥100)119_final_12glc.pdf () |
| CN IECIC Historical Max Use | leave_on | ≤ 20% | Safe (MoS≥100)NMPA IECIC (2025) Entry 00005 (2025) |
| CN IECIC Historical Max Use | rinse_off | ≤ 20% | Safe (MoS≥100)NMPA IECIC (2025) Entry 00005 (2025) |
Layer 3 Formulation Concentration Box-Plot vs. Statutory Limit
Layer 3 — Formulation Usage Guide (Quartiles n≥5) & Physicochemical Compatibility
| Formulation Group | Min – Q1 – Median – Q3 – Max (%) | Role & Mechanism | Source ID |
|---|---|---|---|
| Group A — Aqueous Toner / Serum / Ampoule | 3% · 3.5% · 3.5% · 5% · 8% | Aqueous serum, toner & hydrogel matrix formulation component | Global Starter Formulation Library Statistical Distribution (n=9, EVONIK 7 · GRANT 1 · SEPPIC 1) |
| Group C — Rinse-Off Cleanser / Shampoo / Body Wash | 2% · 3.5% · 4% · 4% · 5.5% | Rinse-off cleanser & surfactant system modifier | Global Starter Formulation Library Statistical Distribution (n=17, EVONIK 16 · SEPPIC 1) |
| Group B — O/W & W/O Emulsion / Lotion / Cream | 1% · 1.875% · 3.5% · 5% · 8% | Emulsion cream & lotion structural / conditioning agent | Global Starter Formulation Library Statistical Distribution (n=12, EVONIK 8 · SEPPIC 3 · GRANT 1) |
| Group D — Sunscreen (UV) / Color Cosmetics / Foundation | 1% · 2.5% · 3% · 3% · 5% | Sun care & color cosmetics dispersion / sensory modifier | Global Starter Formulation Library Statistical Distribution (n=11, EVONIK 9 · GRANT 1 · SEPPIC 1) |
Stratum Corneum Penetration Depth & Bio-Spicule Transdermal Delivery
Under passive topical application, molecules diffuse tortuously through intercellular lipids. Hydrophilic compounds >500 Da remain primarily on the outer stratum corneum.
pH Stability Window (0–14), Thermal Limit & HLB Colloidal Phase Behavior
Outside pH 4–8, risk of hydrolysis, viscosity loss, or ionic dissociation increases.
Thermally stable up to 50°C during standard emulsification.
Cellular & Molecular Target Mechanism Flow
Interactive Synergy Pairings (Solid) & Incompatibility Warnings (Dashed)
Click any green synergy node to jump directly to its monograph, or click a red dashed node to inspect the chemical incompatibility mechanism.
Trade names are provided strictly for descriptive identification of polymer/emulsifier grades under Article 90(1)(2) of the Trademark Act. All trademarks belong to their respective owners.
Academic & Toxicological Synthesis
Tier 2 SynthesisSynthesized strictly from peer-reviewed PubMed abstracts and official toxicological dossiers linked to this ingredient.
Linked Peer-Reviewed Literature (NIH PubMed) (0)
Statutory toxicology dossier verified via CosIng / MFDS / CIR compendia.
Frequently Asked Questions (AEO Position 0)
- Q1. What are the official 7-track regulatory label names for PENTYLENE GLYCOL?
- Standard label names are US PCPC INCI: 'PENTYLENE GLYCOL', EU CosIng: 'PENTYLENE GLYCOL', KR MFDS: 'PENTYLENE GLYCOL (KR MFDS Registered)', CN NMPA IECIC: '1,2-戊二醇', and JP JCIA: 'ペンチレングリコール'.
- Q2. Is PENTYLENE GLYCOL restricted or permitted in EU, US, KR, CN, and JP cosmetics?
- Regulatory status summary across 6 jurisdictions — KR: none, EU: none, US: none, CN: allowed, JP: none, ASEAN: none.
- Q3. What is the typical formulation concentration and optimal pH window for PENTYLENE GLYCOL?
- In aqueous_serum systems, PENTYLENE GLYCOL is typically formulated between 3% and 8% (median 3.5%), with an optimal stability window of pH 4–8.
- Q4. What are the known formulation incompatibilities and synergy pairings for PENTYLENE GLYCOL?
- Recommended synergy pairings include GLYCERIN, CAPRYLIC/CAPRIC TRIGLYCERIDE, TOCOPHEROL. Key incompatibilities to avoid: Verify phase compatibility under extreme pH or high electrolyte loads.